Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer.

Seneviratne MG, Bozkurt S, Patel MI, Seto T, Brooks JD, Blayney DW, Kurian AW, Hernandez-Boussard T.

Cancer. 2018 Dec 4. doi: 10.1002/cncr.31895. [Epub ahead of print]

PMID:
30512191
2.

Utilization of Prostate Cancer Quality Metrics for Research and Quality Improvement: A Structured Review.

Gori D, Dulal R, Blayney DW, Brooks JD, Fantini MP, McDonald KM, Hernandez-Boussard T.

Jt Comm J Qual Patient Saf. 2018 Sep 18. pii: S1553-7250(18)30094-1. doi: 10.1016/j.jcjq.2018.06.004. [Epub ahead of print] Review.

PMID:
30236510
3.

Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.

Gidwani-Marszowski R, Nevedal AL, Blayney DW, Patel M, Kelly PA, Timko C, Ramchandran K, Murrell SS, Asch SM.

Value Health. 2018 Aug;21(8):931-937. doi: 10.1016/j.jval.2018.01.005. Epub 2018 Mar 24.

PMID:
30098670
4.

Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer.

Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T.

EGEMS (Wash DC). 2018 Jun 1;6(1):13. doi: 10.5334/egems.234.

5.

Mining Electronic Health Records to Extract Patient-Centered Outcomes Following Prostate Cancer Treatment.

Hernandez-Boussard T, Kourdis PD, Seto T, Ferrari M, Blayney DW, Rubin D, Brooks JD.

AMIA Annu Symp Proc. 2018 Apr 16;2017:876-882. eCollection 2017.

6.

Southeast Asia's import demand for skim milk powder: Implications for US exporters.

Davis CG, Cessna JG, Blayney DP.

J Dairy Sci. 2018 May;101(5):4676-4689. doi: 10.3168/jds.2017-12848. Epub 2018 Feb 14.

PMID:
29454689
7.

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fynan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S, Patel S, Perez LE, Poust A, Rampal R, Roy V, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Talbott M, Vadhan-Raj S, Vasu S, Wadleigh M, Westervelt P, Burns JL, Pluchino L.

J Natl Compr Canc Netw. 2017 Dec;15(12):1520-1541. doi: 10.6004/jnccn.2017.0175.

PMID:
29223990
8.

Efficacy of Medicaid for Patients With Cancer in California.

Blayney DW.

JAMA Oncol. 2018 Mar 1;4(3):323-325. doi: 10.1001/jamaoncol.2017.4356. No abstract available.

PMID:
29192302
9.

Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning.

Kesler SR, Rao A, Blayney DW, Oakley-Girvan IA, Karuturi M, Palesh O.

Front Hum Neurosci. 2017 Nov 15;11:555. doi: 10.3389/fnhum.2017.00555. eCollection 2017.

10.

Critical Lessons From High-Value Oncology Practices.

Blayney DW, Simon MK, Podtschaske B, Ramsey S, Shyu M, Lindquist C, Milstein A.

JAMA Oncol. 2018 Feb 1;4(2):164-171. doi: 10.1001/jamaoncol.2017.3803.

11.

Choosing Wisely in Oncology: Are We Ready For Value-Based Care?

Rocque G, Blayney DW, Jahanzeb M, Knape A, Markham MJ, Pham T, Shelton J, Sudheendra P, Evans T.

J Oncol Pract. 2017 Nov;13(11):e935-e943. doi: 10.1200/JOP.2016.019281. Epub 2017 Aug 7.

PMID:
28783425
12.

Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center.

Porter JB, Rosenthal EL, Winget M, Smith AS, Seshadri SB, Vetteth Y, Kiamanesh EF, Badwe A, Advani RH, Buyyounouski MK, Coutre S, Dirbas F, Divi V, Dorigo O, Ganjoo KN, Johnston LJ, Recht LD, Shrager JB, Skinner EC, Swetter SM, Visser BC, Blayney DW.

J Oncol Pract. 2017 Aug;13(8):e673-e682. doi: 10.1200/JOP.2017.021139. Epub 2017 Jul 20.

13.

Redesigning Cancer Care Delivery: Views From Patients and Caregivers.

Patel MI, Periyakoil VS, Blayney DW, Moore D, Nevedal A, Asch S, Milstein A, Coker TR.

J Oncol Pract. 2017 Apr;13(4):e291-e302. doi: 10.1200/JOP.2016.017327. Epub 2017 Feb 7.

14.

Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment.

Kesler SR, Adams M, Packer M, Rao V, Henneghan AM, Blayney DW, Palesh O.

Brain Behav. 2017 Feb 6;7(3):e00643. doi: 10.1002/brb3.643. eCollection 2017 Mar.

15.

Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy.

Mackler E, Petersen L, Severson J, Blayney DW, Benitez LL, Early CR, Hough S, Griggs JJ.

J Oncol Pract. 2017 Apr;13(4):e395-e400. doi: 10.1200/JOP.2016.018390. Epub 2017 Feb 14.

PMID:
28195813
16.

The Appropriate Provision of Primary versus Specialist Palliative Care to Cancer Patients: Oncologists' Perspectives.

Gidwani R, Nevedal A, Patel M, Blayney DW, Timko C, Ramchandran K, Kelly PA, Asch SM.

J Palliat Med. 2017 Apr;20(4):395-403. doi: 10.1089/jpm.2016.0399. Epub 2016 Dec 20.

PMID:
27997278
17.

Where Does Dynamic Value Assessment Fit Into Our Role as Agents Advising Our Patients With Cancer?

Blayney DW.

J Oncol Pract. 2016 Dec;12(12):1211-1213. Epub 2016 Oct 31. No abstract available.

PMID:
27943682
18.

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.

Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.

J Clin Oncol. 2016 Sep 20;34(27):3308-14. doi: 10.1200/JCO.2015.65.8013. Epub 2016 Aug 1.

PMID:
27480155
19.

New Paradigms for Patient-Centered Outcomes Research in Electronic Medical Records: An Example of Detecting Urinary Incontinence Following Prostatectomy.

Hernandez-Boussard T, Tamang S, Blayney D, Brooks J, Shah N.

EGEMS (Wash DC). 2016 May 12;4(3):1231. doi: 10.13063/2327-9214.1231. eCollection 2016.

20.

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL.

J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. No abstract available.

PMID:
27247218
21.

Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Kesler SR, Blayney DW.

JAMA Oncol. 2016 Feb;2(2):185-92. doi: 10.1001/jamaoncol.2015.4333.

22.

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL, American Society of Clinical Oncology.

J Clin Oncol. 2015 Aug 10;33(23):2563-77. doi: 10.1200/JCO.2015.61.6706. Epub 2015 Jun 22. No abstract available.

23.

Do Wise Choices Translate Into Cost Savings and Improved Outcomes?

Blayney DW.

J Oncol Pract. 2015 Jul;11(4):344-5. doi: 10.1200/JOP.2015.004937. Epub 2015 Jun 9. No abstract available.

PMID:
26060226
24.

Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer.

Kesler SR, Watson CL, Blayney DW.

Neurobiol Aging. 2015 Aug;36(8):2429-42. doi: 10.1016/j.neurobiolaging.2015.04.015. Epub 2015 May 1.

25.

Detecting unplanned care from clinician notes in electronic health records.

Tamang S, Patel MI, Blayney DW, Kuznetsov J, Finlayson SG, Vetteth Y, Shah N.

J Oncol Pract. 2015 May;11(3):e313-9. doi: 10.1200/JOP.2014.002741.

26.

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349. Epub 2015 May 11.

27.

Transforming data from information to quality improvement: a panel discussion with electronic health record vendors.

Blayney DW.

J Oncol Pract. 2015 May;11(3):174-5. doi: 10.1200/JOP.2015.004267. Epub 2015 Mar 31. No abstract available.

PMID:
25829523
28.

American Society of Clinical Oncology third quality care symposium.

Earle CC, Jacobson JO, Blayney DW.

J Oncol Pract. 2015 May;11(3):167. doi: 10.1200/JOP.2015.004119. Epub 2015 Mar 24. No abstract available.

PMID:
25804987
29.

Administration of oral chemotherapy: results from three rounds of the quality oncology practice initiative.

Zerillo JA, Pham TH, Kadlubek P, Severson JA, Mackler E, Jacobson JO, Blayney DW.

J Oncol Pract. 2015 Mar;11(2):e255-62. doi: 10.1200/JOP.2014.001842.

PMID:
25784581
30.

Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.

Hiatt RA, Tai CG, Blayney DW, Deapen D, Hogarth M, Kizer KW, Lipscomb J, Malin J, Phillips SK, Santa J, Schrag D.

J Natl Cancer Inst. 2015 Mar 11;107(5). pii: djv047. doi: 10.1093/jnci/djv047.

PMID:
25766400
31.

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy.

Knight JS, Blayney DW, Somers EC.

Lupus Sci Med. 2014 Nov 14;1(1):e000051. doi: 10.1136/lupus-2014-000051. eCollection 2014.

32.

Are Patients With Thoracic Malignancies at Risk for Uncontrolled Symptoms?

Patel MI, Williams DC, Wohlforth C, Fisher G, Wakelee HA, Blayney DW.

J Oncol Pract. 2015 Jan;11(1):e98-e102. doi: 10.1200/JOP.2014.001502. Epub 2014 Sep 30.

PMID:
25271246
33.

Development and future of the American Society of Clinical Oncology's Quality Oncology Practice Initiative.

Blayney DW, McNiff K, Eisenberg PD, Gilmore T, Jacobsen PB, Jacobson JO, Kadlubek PJ, Neuss MN, Simone J.

J Clin Oncol. 2014 Dec 10;32(35):3907-13. doi: 10.1200/JCO.2014.56.8899. Epub 2014 Sep 15. No abstract available.

PMID:
25225418
34.

Reply to L.k. Griffeth et al and J.E. Battley et al.

Schnipper LE, Schilsky RL, Hoverman JR, Raghavan D, Lyman GH, Wollins DS, Blayney DW.

J Clin Oncol. 2014 Sep 1;32(25):2812-3. doi: 10.1200/JCO.2014.55.2349. Epub 2014 Jul 14. No abstract available.

PMID:
25024078
35.

Second Annual ASCO Quality Care Symposium.

Blayney DW, Earle CC.

J Oncol Pract. 2014 May;10(3):161. doi: 10.1200/JOP.2014.001448. No abstract available.

PMID:
24839273
36.

Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering, and business methodologies needed to improve value in cancer care delivery?

Patel MI, Moore D, Blayney DW, Milstein A.

J Oncol Pract. 2014 Mar;10(2):e51-4. doi: 10.1200/JOP.2013.000928. Epub 2013 Dec 26. No abstract available.

PMID:
24371302
37.

American Society of Clinical Oncology 2013 top five list in oncology.

Schnipper LE, Lyman GH, Blayney DW, Hoverman JR, Raghavan D, Wollins DS, Schilsky RL.

J Clin Oncol. 2013 Dec 1;31(34):4362-70. doi: 10.1200/JCO.2013.53.3943. Epub 2013 Oct 29. No abstract available.

PMID:
24170249
38.

Myeloid growth factors.

Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Steensma DP, Talbott M, Vadhan-Raj S, Westervelt P, Westmoreland M, Dwyer M, Ho M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Oct 1;11(10):1266-90.

PMID:
24142827
39.

Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.

Kurian AW, Mitani A, Desai M, Yu PP, Seto T, Weber SC, Olson C, Kenkare P, Gomez SL, de Bruin MA, Horst K, Belkora J, May SG, Frosch DL, Blayney DW, Luft HS, Das AK.

Cancer. 2014 Jan 1;120(1):103-11. doi: 10.1002/cncr.28395. Epub 2013 Sep 24.

40.

Computerized prescriber order entry implementation in a physician assistant-managed hematology and oncology inpatient service: effects on workflow and task switching.

Hanauer DA, Zheng K, Commiskey EL, Duck MG, Choi SW, Blayney DW.

J Oncol Pract. 2013 Jul;9(4):e103-14. doi: 10.1200/JOP.2012.000655. Epub 2012 Nov 13.

41.

Measuring and improving quality of care in an academic medical center.

Blayney DW.

J Oncol Pract. 2013 May;9(3):138-41. doi: 10.1200/JOP.2013.000991.

42.

Models that work: incorporating quality principles in different clinical settings.

Krzyzanowska MK, Blayney DW, Bosserman LD, Sullivan TJ.

J Oncol Pract. 2013 May;9(3):135-7. doi: 10.1200/JOP.2013.001028. No abstract available.

43.

Introduction to the ASCO Quality Care Symposium.

Blayney DW, Stovall EL, Earle CC.

J Oncol Pract. 2013 May;9(3):113. doi: 10.1200/JOP.2013.000992. No abstract available.

44.

Measuring the improving quality of outpatient care in medical oncology practices in the United States.

Neuss MN, Malin JL, Chan S, Kadlubek PJ, Adams JL, Jacobson JO, Blayney DW, Simone JV.

J Clin Oncol. 2013 Apr 10;31(11):1471-7. doi: 10.1200/JCO.2012.43.3300. Epub 2013 Mar 11.

PMID:
23478057
45.

Tumor boards (team huddles) aren't enough to reach the goal.

Blayney DW.

J Natl Cancer Inst. 2013 Jan 16;105(2):82-4. doi: 10.1093/jnci/djs523. Epub 2012 Dec 28. No abstract available.

PMID:
23274389
46.

Time to diagnosis and breast cancer stage by race/ethnicity.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

Breast Cancer Res Treat. 2012 Dec;136(3):813-21. doi: 10.1007/s10549-012-2304-1. Epub 2012 Oct 26.

47.

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC.

J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.

48.

The effect of age on delay in diagnosis and stage of breast cancer.

Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.

Oncologist. 2012;17(6):775-82. doi: 10.1634/theoncologist.2011-0469. Epub 2012 May 3.

49.

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.

Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC.

Cancer. 2012 Nov 15;118(22):5463-72. doi: 10.1002/cncr.27581. Epub 2012 Apr 27.

50.

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM, Wollins DS.

J Clin Oncol. 2012 May 10;30(14):1715-24. doi: 10.1200/JCO.2012.42.8375. Epub 2012 Apr 3. Review. No abstract available.

PMID:
22493340

Supplemental Content

Loading ...
Support Center